Monthly Archives: May 2015

Astrazeneca LP et al. v. Breath Limited et al.

Docket No. 2015-1335 NEWMAN (D), DYK, HUGHES May 7, 2015 Non-precedential Brief Summary: DC findings of obviousness affirmed since analysis only requires that the “skilled artisan would have perceived a reasonable expectation of success in making the invention in light … Continue reading

Posted in Generics / ANDA, Obviousness | Leave a comment

Takeda Pharmaceuticals U.S.A., Inc. v. West-Ward Pharmaceutical Corp. et al. and Hikma Americas Inc. et al. (collectively “Hikma”)

Docket No. 2015-1139, 2015-1142 NEWMAN (D), DYK, HUGHES May 6, 2015 Brief Summary: DC denial of Takeda’s motion for preliminary injunction of “paper NDA” (“§ 505(b)(2) application”) holder because it could not show a likelihood of success on the merits … Continue reading

Posted in Generics / ANDA, Inducement to Infringe | Leave a comment

Ponanai Sukumar, et al. v. Nautilus, Inc.

Docket No. 2014-1205 PROST, NEWMAN, REYNA May 4, 2015 Brief Summary: The FC held that under under 35 § USC 292(b) (false marking) a potential competitor may suffer a competitive injury if it has attempted the market” as evidenced by … Continue reading

Posted in False Marking | Leave a comment

Innovention Toys, LLC v. MGA Entertainment, Inc. et al.

Docket No. 2014-1731 Lourie, Plager, Taranto April 29, 2015 Non-precedential Brief Summary: Wilfullness determination reversed because “the gap between the prior art and Innovention’s claims, while large enough to allow the jury to find that MGA did not successfully establish … Continue reading

Posted in Willfullness | Leave a comment